Quarterly report pursuant to Section 13 or 15(d)

Revenues from Contracts and Significant Customers (Company's product revenue) (Details)

v3.24.2.u1
Revenues from Contracts and Significant Customers (Company's product revenue) (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Product revenue, net $ 14,855 $ 16,961 $ 27,885 $ 29,126
Collaboration revenue   183   364
Other revenue   211   259
Net revenue 14,896 17,386 27,926 29,815
Related Party        
Revenue - related party 41 31 41 66
Qbrexza        
Product revenue, net 6,836 8,079 11,853 12,173
Accutane        
Product revenue, net 5,719 5,579 11,538 10,227
Amzeeq        
Product revenue, net 1,205 1,374 1,960 2,568
Zilxi        
Product revenue, net 369 572 642 886
Other Legacy Product Revenue        
Product revenue, net $ 726 $ 1,357 $ 1,892 $ 3,272